Yeonjae Kim

4.0k total citations
69 papers, 1.9k citations indexed

About

Yeonjae Kim is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Yeonjae Kim has authored 69 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 20 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Yeonjae Kim's work include SARS-CoV-2 and COVID-19 Research (16 papers), COVID-19 Clinical Research Studies (13 papers) and Urinary Tract Infections Management (7 papers). Yeonjae Kim is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (16 papers), COVID-19 Clinical Research Studies (13 papers) and Urinary Tract Infections Management (7 papers). Yeonjae Kim collaborates with scholars based in South Korea, Ethiopia and United States. Yeonjae Kim's co-authors include Bum Sik Chin, So Yeon Kim, Jin Yong Kim, Joon-Sung Joh, Gayeon Kim, Hyoung‐Shik Shin, Ina Jeong, Ji Yeon Lee, Hyunjoo Pai and Jieun Kim and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Yeonjae Kim

63 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yeonjae Kim South Korea 22 1.1k 341 274 250 223 69 1.9k
Guiqing He China 12 795 0.7× 177 0.5× 329 1.2× 247 1.0× 75 0.3× 24 1.5k
Michael Rajnik United States 14 1.3k 1.2× 361 1.1× 251 0.9× 196 0.8× 82 0.4× 37 2.5k
Ronghua Jin China 18 1.0k 1.0× 301 0.9× 395 1.4× 438 1.8× 74 0.3× 70 2.1k
Alireza Tahamtan Iran 19 776 0.7× 108 0.3× 273 1.0× 480 1.9× 268 1.2× 53 1.8k
Dingwen Hu China 12 1.2k 1.1× 394 1.2× 167 0.6× 471 1.9× 48 0.2× 20 2.0k
Xiangao Jiang China 9 1.3k 1.2× 654 1.9× 275 1.0× 135 0.5× 48 0.2× 34 2.0k
Yu Ma China 34 557 0.5× 154 0.5× 313 1.1× 814 3.3× 129 0.6× 171 3.1k
Baoli Zhu China 15 621 0.6× 194 0.6× 234 0.9× 180 0.7× 56 0.3× 45 1.2k
Kun Su China 10 1.6k 1.5× 318 0.9× 162 0.6× 124 0.5× 105 0.5× 28 2.0k

Countries citing papers authored by Yeonjae Kim

Since Specialization
Citations

This map shows the geographic impact of Yeonjae Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeonjae Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeonjae Kim more than expected).

Fields of papers citing papers by Yeonjae Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yeonjae Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeonjae Kim. The network helps show where Yeonjae Kim may publish in the future.

Co-authorship network of co-authors of Yeonjae Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Yeonjae Kim. A scholar is included among the top collaborators of Yeonjae Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yeonjae Kim. Yeonjae Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Yeonjae, Sung Woo Kim, Hyun Jung Kim, et al.. (2025). Anti‐Glycation and Anti‐Aging Efficacy of Newly Synthesized Antioxidant With Autophagy Stimulating Activity. Journal of Cosmetic Dermatology. 24(5). e70240–e70240.
2.
Chin, Bum Sik, Yeonjae Kim, Gayeon Kim, et al.. (2024). Characterization of Incident Hepatitis C Virus Infection among People Living with HIV in a HIV Clinic in Korea. Infection and Chemotherapy. 56(4). 544–544.
3.
Kim, Yeonjae, et al.. (2024). Comparative characteristics of fatigue in irritable bowel syndrome and inflammatory bowel disease: A systematic review and meta-analysis. Journal of Psychosomatic Research. 177. 111589–111589. 6 indexed citations
4.
Lim, Michelle, Juyeon Jung, Sung Woo Kim, et al.. (2024). Skin Barrier-Improving and Skin-Soothing Effects of Autophagy-Activating Peptide on Sensitive Skin. Cosmetics. 11(6). 223–223. 1 indexed citations
5.
Kim, Sung Woo, Yeonjae Kim, Juyeon Jung, et al.. (2024). Clinical Efficacy of Endocannabinoid-Mimetic Fatty Acid Amide as a Skin-Soothing Ingredient. Cosmetics. 11(6). 225–225.
6.
Park, Wan Beom, Eu Suk Kim, Yeonjae Kim, et al.. (2023). Possibility of Decreasing Incidence of Human Immunodeficiency Virus Infection in Korea. Infection and Chemotherapy. 55(4). 451–451. 2 indexed citations
7.
Kim, Min-Kyung, Kyung‐Shin Lee, Sin Young Ham, et al.. (2023). Real-World Effectiveness of Nirmatrelvir-Ritonavir and Its Acceptability in High-Risk COVID-19 Patients. Journal of Korean Medical Science. 38(35). e272–e272. 2 indexed citations
8.
Lee, So Hee, Jin‐Won Noh, Yeonjae Kim, et al.. (2022). Expert Consensus on Measures to Promote Physical and Psychological Health among COVID-19-Related Healthcare Workers in Korea using Delphi Technique. Infection and Chemotherapy. 54(2). 247–247. 6 indexed citations
9.
Kim, Yeonjae, et al.. (2021). Response to the COVID-19 Outbreak in The Emergency Department Designed for Emerging Infectious Diseases in Korea. Infection and Chemotherapy. 53(1). 84–84. 2 indexed citations
10.
Cheon, Shinhye, Yuri Kim, Nguyễn Thị Hải Yến, et al.. (2021). Longevity of seropositivity and neutralizing antibodies in recovered MERS patients: a 5-year follow-up study. Clinical Microbiology and Infection. 28(2). 292–296. 8 indexed citations
11.
Kim, Eu Suk, Bum Sik Chin, Chang Kyung Kang, et al.. (2020). Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19. Journal of Korean Medical Science. 35(13). e142–e142. 229 indexed citations
12.
Kim, Bongyoung, Mi-Ran Seo, Jieun Kim, et al.. (2020). Molecular Epidemiology of Ciprofloxacin-Resistant Escherichia coli Isolated from Community-Acquired Urinary Tract Infections in Korea. Infection and Chemotherapy. 52(2). 194–194. 14 indexed citations
13.
Ys, Kim, Abdimadiyeva Aigerim, Yuri Kim, et al.. (2020). Sustained responses of neutralizing antibodies against MERS-CoV in recovered patients and their therapeutic applicability.. Clinical Infectious Diseases. 5 indexed citations
14.
Park, Wan Beom, Kang Il Jun, Jae‐Phil Choi, et al.. (2018). Correlation between Pneumonia Severity and Pulmonary Complications in Middle East Respiratory Syndrome. Journal of Korean Medical Science. 33(24). e169–e169. 70 indexed citations
15.
Kim, Yeonjae, Bum Sik Chin, Gayeon Kim, & Hyoung‐Shik Shin. (2018). Integrase Strand Transfer Inhibitor Resistance Mutations in Antiretroviral Treatment-naïve Patients in Korea: a Prospective, Observational Study. Journal of Korean Medical Science. 33(25). e173–e173. 4 indexed citations
16.
Kim, Yeonjae, Mi-Ran Seo, Jieun Kim, et al.. (2017). Usefulness of Blood Cultures and Radiologic Imaging Studies in the Management of Patients with Community-Acquired Acute Pyelonephritis. Infection and Chemotherapy. 49(1). 22–22. 28 indexed citations
17.
Park, Jae-Keun, et al.. (2015). Polymicrobial Purulent Pericarditis Probably caused by a Broncho-Lymph Node-Pericardial Fistula in a Patient with Tuberculous Lymphadenitis. Infection and Chemotherapy. 47(4). 261–261. 7 indexed citations
19.
Kim, Yeonjae, et al.. (2009). A case of organizing pneumonia with cryoglobulinemia. The Korean Journal of Internal Medicine. 77. 1183–1187. 1 indexed citations
20.
Kim, Yeonjae, et al.. (2003). The clinical investigation for determining the etiology of bronchial anthracofibrosis. The Korean Journal of Internal Medicine. 65(6). 665–674. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026